en
/
sv
About Elicera
Elicera in brief
Board
Management
Elicera's history
Immuno-oncology
What is immuno-oncology?
Oncolytic virus
CAR T-cell therapy
Technology
Strengths
ELC-001
ELC-100
ELC-201
ELC-301
ELC-401
Patents
Pipeline
Pipeline
Clinical trials
Investors
Press Releases
Corporate Governance
the Share
Financial Reports
Financial Calendar
Events
Planned IPO
News
News
Press Releases
Events
Contact
en
/
sv
Press Releases
All
Regulatory
Mar 22, 2021
Elicera announces appointment of ATMP specialist Karin Hoogendoorn to the Board
Regulatory
Read more
Jan 11, 2021
Elicera Therapeutics recruits CFO
Regulatory
Read more
Jan 8, 2021
Elicera Therapeutics invitation to company presentation (in Swedish)
Regulatory
Read more
Oct 5, 2020
Elicera Therapeutics completes oversubscribed share issue and launches unique immuno-oncology company with focus on CAR T-cells and oncolytic viruses
Regulatory
Read more
No regulatory Press Releases
Sign up for Press Releases
By filling out the form you are approving that Elicera stores your information. Read more about our integrity policy
here
.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
